APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lafutidine Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lafutidine Tablets Market Outlook and Growth Opportunities 2026

Report ID 174006320429 December 2025196 pages

Choose your research edition.

Industry ResearchLafutidine Tablets Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Lafutidine Tablets Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Lafutidine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lafutidine Tablets Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Lafutidine Tablets Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Lafutidine Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lafutidine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lafutidine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lafutidine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lafutidine Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lafutidine Tablets market include Yuekang Pharmaceutical Group Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Shandong Qidu Pharmaceutical Co., Ltd., Jiangsu Runbang Pharmaceutical Co., Ltd., China Resources Double Crane Pharmaceutical Co., Ltd., Hubei Shubang Pharmaceutical Co., Ltd. and Chengdu Hengrui Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lafutidine Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lafutidine Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lafutidine Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lafutidine Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Lafutidine Tablets Segment by Company

Yuekang Pharmaceutical Group Co., Ltd.

Sichuan Kelun Pharmaceutical Co., Ltd.

Shandong Qidu Pharmaceutical Co., Ltd.

Jiangsu Runbang Pharmaceutical Co., Ltd.

China Resources Double Crane Pharmaceutical Co., Ltd.

Hubei Shubang Pharmaceutical Co., Ltd.

Chengdu Hengrui Pharmaceutical Co., Ltd.

Lafutidine Tablets Segment by Type

10mg

5mg

Lafutidine Tablets Segment by Application

Hospital

Clinic

Other

Lafutidine Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lafutidine Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lafutidine Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lafutidine Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Lafutidine Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lafutidine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lafutidine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lafutidine Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lafutidine Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lafutidine Tablets industry.

Chapter 3: Detailed analysis of Lafutidine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lafutidine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lafutidine Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lafutidine Tablets Industry Trends Table 2. Lafutidine Tablets Industry Drivers Table 3. Lafutidine Tablets Industry Opportunities and Challenges Table 4. Lafutidine Tablets Industry Restraints Table 5. Global Lafutidine Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lafutidine Tablets Revenue Share by Company (2021-2026) Table 7. Global Lafutidine Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Lafutidine Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Lafutidine Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Lafutidine Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lafutidine Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Lafutidine Tablets Company, Product Type & Application Table 13. Global Lafutidine Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lafutidine Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10mg Table 18. Significant Companies of 5mg Table 19. Global Lafutidine Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Lafutidine Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Lafutidine Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Lafutidine Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Lafutidine Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Lafutidine Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lafutidine Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Lafutidine Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Lafutidine Tablets Sales Value Share by Type (2021-2026) Table 28. Global Lafutidine Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Lafutidine Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Lafutidine Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Lafutidine Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Lafutidine Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Lafutidine Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Lafutidine Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Lafutidine Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Lafutidine Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Lafutidine Tablets Sales Value Share by Application (2021-2026) Table 41. Global Lafutidine Tablets Sales Value Share by Application (2027-2032) Table 42. Global Lafutidine Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Lafutidine Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Lafutidine Tablets Sales Market Share by Region (2021-2026) Table 45. Global Lafutidine Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Lafutidine Tablets Sales Market Share by Region (2027-2032) Table 47. Global Lafutidine Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Lafutidine Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Lafutidine Tablets Sales Value Share by Region (2021-2026) Table 50. Global Lafutidine Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Lafutidine Tablets Sales Value Share by Region (2027-2032) Table 52. Global Lafutidine Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Lafutidine Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Lafutidine Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Lafutidine Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Lafutidine Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Lafutidine Tablets Sales Market Share by Country (2021-2026) Table 58. Global Lafutidine Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Lafutidine Tablets Sales Market Share by Country (2027-2032) Table 60. Global Lafutidine Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Lafutidine Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Lafutidine Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Lafutidine Tablets Sales Value Market Share by Country (2027-2032) Table 64. Yuekang Pharmaceutical Group Co., Ltd. Company Information Table 65. Yuekang Pharmaceutical Group Co., Ltd. Business Overview Table 66. Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Product Portfolio Table 68. Yuekang Pharmaceutical Group Co., Ltd. Recent Development Table 69. Sichuan Kelun Pharmaceutical Co., Ltd. Company Information Table 70. Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview Table 71. Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio Table 73. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Development Table 74. Shandong Qidu Pharmaceutical Co., Ltd. Company Information Table 75. Shandong Qidu Pharmaceutical Co., Ltd. Business Overview Table 76. Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio Table 78. Shandong Qidu Pharmaceutical Co., Ltd. Recent Development Table 79. Jiangsu Runbang Pharmaceutical Co., Ltd. Company Information Table 80. Jiangsu Runbang Pharmaceutical Co., Ltd. Business Overview Table 81. Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio Table 83. Jiangsu Runbang Pharmaceutical Co., Ltd. Recent Development Table 84. China Resources Double Crane Pharmaceutical Co., Ltd. Company Information Table 85. China Resources Double Crane Pharmaceutical Co., Ltd. Business Overview Table 86. China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio Table 88. China Resources Double Crane Pharmaceutical Co., Ltd. Recent Development Table 89. Hubei Shubang Pharmaceutical Co., Ltd. Company Information Table 90. Hubei Shubang Pharmaceutical Co., Ltd. Business Overview Table 91. Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio Table 93. Hubei Shubang Pharmaceutical Co., Ltd. Recent Development Table 94. Chengdu Hengrui Pharmaceutical Co., Ltd. Company Information Table 95. Chengdu Hengrui Pharmaceutical Co., Ltd. Business Overview Table 96. Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio Table 98. Chengdu Hengrui Pharmaceutical Co., Ltd. Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Lafutidine Tablets Distributors List Table 102. Lafutidine Tablets Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Lafutidine Tablets Product Image Figure 2. Global Lafutidine Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lafutidine Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lafutidine Tablets Sales (2021-2032) & (K Units) Figure 5. Global Lafutidine Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Lafutidine Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10mg Image Figure 10. 5mg Image Figure 11. Global Lafutidine Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Lafutidine Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Lafutidine Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Lafutidine Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Lafutidine Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Lafutidine Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Lafutidine Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Lafutidine Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Lafutidine Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Lafutidine Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Lafutidine Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Lafutidine Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Lafutidine Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Lafutidine Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Lafutidine Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Lafutidine Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Lafutidine Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Lafutidine Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Lafutidine Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Lafutidine Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Lafutidine Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Lafutidine Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Lafutidine Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Lafutidine Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Lafutidine Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Lafutidine Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Lafutidine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Lafutidine Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Lafutidine Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 5mg
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yuekang Pharmaceutical Group Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Shandong Qidu Pharmaceutical Co., Ltd.
  • Jiangsu Runbang Pharmaceutical Co., Ltd.
  • China Resources Double Crane Pharmaceutical Co., Ltd.
  • Hubei Shubang Pharmaceutical Co., Ltd.
  • Chengdu Hengrui Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lafutidine Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Lafutidine Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Lafutidine Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lafutidine Tablets Market Dynamics
  1. 2.1 Lafutidine Tablets Industry Trends
  2. 2.2 Lafutidine Tablets Industry Drivers
  3. 2.3 Lafutidine Tablets Industry Opportunities and Challenges
  4. 2.4 Lafutidine Tablets Industry Restraints
3 Lafutidine Tablets Market by Company
  1. 3.1 Global Lafutidine Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Lafutidine Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Lafutidine Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Lafutidine Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Lafutidine Tablets Company Ranking (2024-2026)
  6. 3.6 Global Lafutidine Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Lafutidine Tablets Company Product Type and Application
  8. 3.8 Global Lafutidine Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lafutidine Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lafutidine Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lafutidine Tablets Market by Type
  1. 4.1 Lafutidine Tablets Type Introduction
  2. 4.1.1 10mg
  3. 4.1.2 5mg
  4. 4.2 Global Lafutidine Tablets Sales Volume by Type
  5. 4.2.1 Global Lafutidine Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lafutidine Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Lafutidine Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Lafutidine Tablets Sales Value by Type
  9. 4.3.1 Global Lafutidine Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lafutidine Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Lafutidine Tablets Sales Value Share by Type (2021-2032)
5 Lafutidine Tablets Market by Application
  1. 5.1 Lafutidine Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Lafutidine Tablets Sales Volume by Application
  6. 5.2.1 Global Lafutidine Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lafutidine Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Lafutidine Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Lafutidine Tablets Sales Value by Application
  10. 5.3.1 Global Lafutidine Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lafutidine Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Lafutidine Tablets Sales Value Share by Application (2021-2032)
6 Lafutidine Tablets Regional Sales and Value Analysis
  1. 6.1 Global Lafutidine Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lafutidine Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Lafutidine Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Lafutidine Tablets Sales by Region (2027-2032)
  5. 6.3 Global Lafutidine Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lafutidine Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lafutidine Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lafutidine Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Lafutidine Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lafutidine Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Lafutidine Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lafutidine Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Lafutidine Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lafutidine Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lafutidine Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lafutidine Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Lafutidine Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lafutidine Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lafutidine Tablets Sales Value Share by Country, 2025 VS 2032
7 Lafutidine Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Lafutidine Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lafutidine Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lafutidine Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Lafutidine Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Lafutidine Tablets Sales by Country (2027-2032)
  6. 7.4 Global Lafutidine Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lafutidine Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lafutidine Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lafutidine Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lafutidine Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lafutidine Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yuekang Pharmaceutical Group Co., Ltd.
  2. 8.1.1 Yuekang Pharmaceutical Group Co., Ltd. Company Information
  3. 8.1.2 Yuekang Pharmaceutical Group Co., Ltd. Business Overview
  4. 8.1.3 Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Product Portfolio
  6. 8.1.5 Yuekang Pharmaceutical Group Co., Ltd. Recent Developments
  7. 8.2 Sichuan Kelun Pharmaceutical Co., Ltd.
  8. 8.2.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
  12. 8.2.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Shandong Qidu Pharmaceutical Co., Ltd.
  14. 8.3.1 Shandong Qidu Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Shandong Qidu Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
  18. 8.3.5 Shandong Qidu Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Jiangsu Runbang Pharmaceutical Co., Ltd.
  20. 8.4.1 Jiangsu Runbang Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Jiangsu Runbang Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
  24. 8.4.5 Jiangsu Runbang Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 China Resources Double Crane Pharmaceutical Co., Ltd.
  26. 8.5.1 China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 China Resources Double Crane Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
  30. 8.5.5 China Resources Double Crane Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Hubei Shubang Pharmaceutical Co., Ltd.
  32. 8.6.1 Hubei Shubang Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Hubei Shubang Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
  36. 8.6.5 Hubei Shubang Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Chengdu Hengrui Pharmaceutical Co., Ltd.
  38. 8.7.1 Chengdu Hengrui Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Chengdu Hengrui Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
  42. 8.7.5 Chengdu Hengrui Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lafutidine Tablets Value Chain Analysis
  2. 9.1.1 Lafutidine Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lafutidine Tablets Sales Mode & Process
  6. 9.2 Lafutidine Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lafutidine Tablets Distributors
  9. 9.2.3 Lafutidine Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst